Between the 4th and 5th of November, we’ll be at the 17th ANNUAL CONFERENCE of the German Society for Neuromodulation at: Victor’s Residenz-Hotel GeraBerliner Strasse
Aleva Neurotherapeutics SA Announces MRI Approval for its directSTIM™ Deep Brain Stimulation System Lausanne, Switzerland, 14 September 2022 – Aleva Neurotherapeutics SA, the company that
In order to support our continued growth, we are looking for a Medical Device Software Project Manager and a Software Engineer. Medical Device Software Project
U.S. FDA grants Aleva Neurotherapeutics approval for an Investigational Device Exemption (IDE) study on directSTIM™ Directional Deep Brain Stimulation System Aleva is committed to starting